Literature DB >> 22430066

Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 3: effect of moisture.

Ken K Qian1, Dale E Wurster, Robin H Bogner.   

Abstract

PURPOSE: Amorphization of crystalline compounds using mesoporous media is a promising technique to improve the solubility and drug release of poorly-soluble compounds. The objective of this paper is to understand the effect of moisture on the capacity and performance of vapor-phase mediated amorphization.
METHODS: Mesoporous silicon dioxide (SiO(2)) and crystalline naphthalene were used as the model system. The effect of moisture on the amorphization capacity of naphthalene was determined using adsorption chambers with various levels of relative humidity. Enthalpy and capacity of water vapor adsorption on SiO(2) were measured using isothermal microcalorimetry and thermogravimetry.
RESULTS: Moisture not only suppressed the amorphization capacity of naphthalene, but reversed an already-amorphized formulation as well. On the other hand, through the same competitive interaction, improved drug release and enhanced solubility were obtained. The initial supersaturation was followed by an entropy-driven crystallization. In addition, moisture-induced siloxane bond fracture was found at normal processing conditions, which led to the changes in silica surface chemistry. However, the implication in amorphization has not reached a definitive conclusion.
CONCLUSIONS: Humidity during processing and storage must be carefully controlled for this type of amorphous formulation. Further investigation is needed to better understand the moisture-induced changes of silica.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22430066     DOI: 10.1007/s11095-012-0734-4

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

Review 1.  Amorphous pharmaceutical solids: preparation, characterization and stabilization.

Authors:  L Yu
Journal:  Adv Drug Deliv Rev       Date:  2001-05-16       Impact factor: 15.470

2.  Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. IV. Study on reduced-pressure mixing for practical use of amorphous mixtures of flufenamic acid.

Authors:  T Konno
Journal:  Chem Pharm Bull (Tokyo)       Date:  1990-07       Impact factor: 1.645

Review 3.  Characteristics and significance of the amorphous state in pharmaceutical systems.

Authors:  B C Hancock; G Zografi
Journal:  J Pharm Sci       Date:  1997-01       Impact factor: 3.534

4.  Interaction of medicinals and porous powder. I. Anomalous thermal behavior of porous glass mixtures.

Authors:  Y Nakai; K Yamamoto; K Terada; J Ichikawa
Journal:  Chem Pharm Bull (Tokyo)       Date:  1984-11       Impact factor: 1.645

5.  Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 2: amorphization capacity and mechanisms of interaction.

Authors:  Ken K Qian; Steven L Suib; Robin H Bogner
Journal:  J Pharm Sci       Date:  2011-06-07       Impact factor: 3.534

6.  Amorphization of Indomethacin by Co-Grinding with Neusilin US2: amorphization kinetics, physical stability and mechanism.

Authors:  Deepak Bahl; Robin H Bogner
Journal:  Pharm Res       Date:  2006-08-23       Impact factor: 4.200

Review 7.  Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems.

Authors:  Ken K Qian; Robin H Bogner
Journal:  J Pharm Sci       Date:  2011-10-04       Impact factor: 3.534

8.  Spontaneous crystalline-to-amorphous phase transformation of organic or medicinal compounds in the presence of porous media, part 1: thermodynamics of spontaneous amorphization.

Authors:  Ken K Qian; Robin H Bogner
Journal:  J Pharm Sci       Date:  2011-02-18       Impact factor: 3.534

9.  Comparison of the ability of various pharmaceutical silicates to amorphize and enhance dissolution of indomethacin upon co-grinding.

Authors:  Deepak Bahl; John Hudak; Robin H Bogner
Journal:  Pharm Dev Technol       Date:  2008       Impact factor: 3.133

10.  Increasing the dissolution rate of a low-solubility drug through a crystalline-amorphous transition: a case study with indomethacin [correction of indomethicin].

Authors:  Xiaohong Pan; Thomas Julian; Larry Augsburger
Journal:  Drug Dev Ind Pharm       Date:  2008-02       Impact factor: 3.225

View more
  1 in total

1.  Characterization of medicinal compounds confined in porous media by neutron vibrational spectroscopy and first-principles calculations: a case study with ibuprofen.

Authors:  Ken K Qian; Wei Zhou; Xiaoming Xu; Terrence J Udovic
Journal:  Pharm Res       Date:  2012-05-15       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.